OnCo

issue-98

All tags →

No description yet: the sentence for this tag has not been written. 1 record carries it: 1 trial.

Related tags
1 records
LITESPARK-011
NCT04586231
In LITESPARK-011, belzutifan plus lenvatinib held advanced clear-cell kidney cancer in check for about four months longer than cabozantinib in people whose cancer had grown after immunotherapy, but at the interim look it had not been shown to help them live longer; a final survival analysis is still to come.

This tag as JSON · API